The Use of Long-Acting Injectable Antipsychotics in Schizophrenia Seiya MiyamotoW. Wolfgang Fleischhacker Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor) Open access 19 April 2017 Pages: 117 - 126
Pharmacogenomics of Antipsychotic Drugs Jian-Ping ZhangAnil K. Malhotra Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor) 02 May 2017 Pages: 127 - 138
Targeting the Immune System With Pharmacotherapy in Schizophrenia Jennifer K. MelbourneBenjamin FeinerRajiv P. Sharma Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor) 18 April 2017 Pages: 139 - 151
Exercise Treatments for Psychosis: a Review Vijay A. MittalTeresa VargasStewart A. Shankman Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor) 18 April 2017 Pages: 152 - 166
Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders Sergi Ferré Substance Use Disorders (FG Moeller, Section Editor) Open access 22 April 2017 Pages: 167 - 183
Pregnancy and the Opioid Epidemic Kelley SaiaHendree JonesMishka Terplan Substance Use Disorders (FG Moeller, Section Editor) 19 April 2017 Pages: 184 - 195
The ABCD Study of Neurodevelopment: Identifying Neurocircuit Targets for Prevention and Treatment of Adolescent Substance Abuse James M. BjorkLisa K. StraubMichael C. Neale Substance Use Disorders (FG Moeller, Section Editor) 20 April 2017 Pages: 196 - 209
The Role of 5-HT2a/2c Receptors in Nociception and Opioid Antinociception: a Review of the Preclinical Literature Kumiko LippoldWilliam Dewey Substance Use Disorders (FG Moeller, Section Editor) 25 April 2017 Pages: 210 - 220
Antagonist Treatment for Opioid Dependence: Promise and Hurdles Evgeny KrupitskyElena BlokhinaGeorge Woody Substance Use Disorders (FG Moeller, Section Editor) 20 April 2017 Pages: 221 - 230